ribavirin has been researched along with Acute Disease in 159 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (5.66) | 18.7374 |
1990's | 22 (13.84) | 18.2507 |
2000's | 80 (50.31) | 29.6817 |
2010's | 45 (28.30) | 24.3611 |
2020's | 3 (1.89) | 2.80 |
Authors | Studies |
---|---|
Kryczka, W | 1 |
Alves, R; Carias, E; Correia, AL; Figueiredo, A; Guedes Marques, M; Leal, R; Leitão, J; Pimenta, AC; Rodrigues, L; Romãozinho, C; Santos, L | 1 |
Carter, M; Fitzmaurice, MG; Jafri, SM; Nagai, S; Singh, A; Solsrud, K; Yeddula, S | 1 |
Berg, T; Boeker, KHW; Buggisch, P; C-Registry, GH; Günther, R; Hinrichsen, H; Klinker, H; Manns, MP; Mauss, S; Müller, T; Serfert, Y; Wiegand, J; Zeuzem, S | 1 |
Cheng, GS; Kicska, GA; Kinahan, PE; Li, T; Liu, L; Pipavath, SNJ; Wu, W | 1 |
Crossan, CL; Dalton, H; Donnelly, MC; Hayes, PC; Scobie, L; Simpson, KJ | 1 |
Kamar, N; Pischke, S | 1 |
Albillos Martínez, A; Flores de Miguel, A; Guerrero García, A; Ríos León, R; Rodríguez de Santiago, E; Rodríguez Gandía, MA; Sánchez Rodríguez, E; Tenorio Cañamás, MT | 1 |
Buzzetti, E; Davidson, BR; Gurusamy, KS; Kalafateli, M; Thorburn, D; Tsochatzis, E | 2 |
Brainard, DM; Chung, RT; Fierer, DS; Hughes, MD; Kim, AY; Kiser, JJ; Luetkemeyer, A; Marks, KM; McHutchison, JG; Naggie, S; Peters, MG; Roa, J; Rwema, S; Vu, V | 1 |
Chu, CJ; Hou, MC; Huang, YH; Wu, SH | 1 |
Castelnovo, D; Fisher, M; Gilleece, Y; Keller, M; Mistry, H; Tibble, J; Webster, DP; Wojcikiewicz, T | 1 |
Berg, T; Buggisch, P; Cornberg, M; Deterding, K; Diepolder, H; Feyerabend, S; Galle, PR; Großhennig, A; Grüner, N; Hinrichsen, H; Jung, MC; Koch, A; Lüth, S; Malek, N; Manns, MP; Potthoff, A; Rogalska-Taranta, M; Schlaphoff, V; Spengler, U; Wedemeyer, H; Wiegand, J | 1 |
Applegate, T; Cherepanov, V; Dore, GJ; Feld, JJ; Grebely, J; Hellard, M; Kaldor, JM; Lloyd, AR; Matthews, GV; Petoumenos, K; Sherker, A; Yeung, B | 1 |
Angarano, G; Babudieri, S; Di Perri, G; Fabris, P; Fasano, M; Marino, N; Pizzigallo, E; Sagnelli, E; Santantonio, T; Toti, M; Tundo, P | 1 |
Ahmed, AI; Aziz, IA; Bahnasy, KA; Fathelbab, IF; Hafez, TA; Kamal, SM; Kassim, SK; Mahmoud, S; Mansour, HM | 1 |
Bertuzzo, VR; Calderaro, A; Morelli, MC; Pinna, AD; Ravaioli, M; Viale, P | 1 |
Buti, M; Gironés, R; Mínguez, B; Quer, J; Riveiro-Barciela, M; Rodriguez-Frías, F | 1 |
Cavero-Escribano, T; Gutiérrez-Martínez, E; Hernández-Martínez, E; Manzano-Peña, MT; Morales-Ruiz, E; Muñoz-Gómez, R; Praga-Terente, M | 1 |
Gatanaga, H; Igari, T; Ishikane, M; Kikuchi, Y; Masaki, N; Nozaki, Y; Oka, S; Tsukada, K; Watanabe, K; Yanase, M | 1 |
Blanco, JL; Gatell, JM; González-Cordón, A; Laguno, M; Loncà, M; Mallolas, J; Martínez, E; Martínez-Rebollar, M; Monteiro, P; Pérez, I; Rojas, JF; Torres, B | 1 |
Aikata, H; Chayama, K; Fujino, H; Fukuhara, T; Hiramatsu, A; Imamura, M; Kan, H; Kawaoka, T; Morio, R; Sasaki, T | 1 |
Aghemo, A; Berardinelli, L; D'Ambrosio, R; Fabrizi, F; Martin, P; Messa, P; Pallotti, F | 1 |
Abravanel, F; Alric, L; Anty, R; Bureau, C; Gérolami, R; Guillaume, M; Izopet, J; Kamar, N; Nana, J; Pariente, A; Péron, JM; Renou, C; Robic, MA; Vinel, JP | 1 |
Akhavan, S; Charlotte, F; Mallet, M; Mouri, S; Poynard, T; Rudler, M; Thabut, D; Thibault, V | 1 |
Ayoub, WS; Lutchman, GA; Nguyen, MH; Nguyen, NH; Yee, BE; Yip, B; Zhang, B | 1 |
Arends, JE; Bierman, WF; Claassen, MA; Hullegie, SJ; Koopmans, PP; Lauw, FN; Leyten, EM; Newsum, AM; Posthouwer, D; Richter, C; Rijnders, BJ; van den Berk, GE; van der Meer, JT; van Eeden, A | 1 |
Di Martino, V; Prati, C; Thevenot, T; Verhoeven, F; Weil-Verhoeven, D; Wendling, D | 1 |
Bhasin, D; Pollinger, H; Rubin, RA; Shrestha, R; Stein, L; Tracy, B | 1 |
Arends, JE; Hoepelman, AI; Mudrikova, T; Schaar, CG; Schrover, IM | 1 |
Fasano, M; Santantonio, T | 1 |
Bhattacharyya, I; Cohen, DM; Islam, N; Katz, J; Ojha, J; Stewart, CM | 1 |
El-Shamy, A; Hayashi, Y; Hotta, H; Imoto, S; Kim, SR; Kitai, S; Kudo, M; Mita, K; Muramatsu, A; Sasase, N; Taniguchi, M | 1 |
Dintsios, CM; Gerlach, T; Haverkamp, A; Krauth, C; Manns, MP; Pape, G; Wedemeyer, H; Wiegand, J | 1 |
Birch, CE; Bowen, MJ; Chung, RT; Kim, AY; McGovern, BH; Nagami, EH; Reyor, LL | 1 |
Nelson, M; Page, E; Rockstroh, JK; Vogel, M | 1 |
Cadranel, JF; Lahmek, P; Morin, T; Pariente, A; Rabaud, C; Silvain, C | 1 |
Dore, GJ; French, R; Grebely, J; Haber, PS; Hellard, M; Kaldor, JM; Lloyd, AR; Marks, P; Matthews, GV; McCaughan, G; Petoumenos, K; Rawlinson, W; van Beek, I; White, P; Yeung, B | 1 |
Fischler, B; Friman, S; Gerdén, B; Josephson, F; Karlström, O; Lagging, M; Sangfelt, P; Schvarz, R; Uhnoo, I; Weiland, O; Wejstål, R | 1 |
Fainboim, H; García, D; Muñoz, A | 1 |
González de Dios, J; Ochoa Sangrador, C | 1 |
Chang, HH; Chen, IM; Shih, CC; Wang, BY; Yang, AH | 1 |
Borden, KL; Culjkovic-Kraljacic, B | 1 |
Lerias de Almeida, PR | 1 |
Alter, HJ; Haynes-Williams, V; Heller, T; Herrine, SK; Hoofnagle, JH; Liang, TJ; Loomba, R; McBurney, R; Park, Y; Rehermann, B; Rivera, MM | 1 |
Blanco, JL; Calvo, M; González, A; Laguno, M; Larrousse, M; Loncà, M; Mallolas, J; Martínez, E; Martínez-Rebollar, M; Muñoz, A | 1 |
Arama, V; Gliga, S; Popescu, C | 1 |
Dougherty, KA; Fried, MW; McGowan, CE | 1 |
Borentain, P; Colson, P; Gerolami, R; Motte, A; Raissouni, F; Solas, C | 1 |
Blanco, JL; Calvo, M; Costa, J; Gatell, JM; González-Cordón, A; Laguno, M; Larrousse, M; Loncá, M; Mallolas, J; Martínez, E; Martínez-Rebollar, M; Muñoz, A; Perez, I | 1 |
Baumert, TF; Dill, MT; Duong, FHT; Filipowicz, M; Heim, MH; Makowska, Z; Merkofer, F; Terracciano, L; Tornillo, L | 1 |
Bessede, T; Buffet, C; Charpentier, B; Durrbach, A; Hassan, Q; Roche, B; Samuel, D | 1 |
Cacopardo, B; Fatuzzo, F; Montineri, A; Nunnari, G; Portelli, V; Savalli, F | 1 |
Driver, TH; Saxena, V; Terrault, N | 1 |
Feld, JJ | 1 |
Bartolucci, GB; Chemello, L; Rinaldi, R; Scaggiante, R; Trevisan, A | 1 |
Pawlotsky, JM | 1 |
Benhamou, Y; Bernard, B; Di Martino, V; Moussalli, J; Myers, RP; Poynard, T; Ratziu, V; Regimbeau, C; Thabut, D | 1 |
Feray, C; Roche, B; Samuel, D | 1 |
Bourlière, M; Halfon, P; Portal, I | 1 |
Grangé, JD | 2 |
Durández Lazaro, R; Fábregas Puigtió, S; Planas Vilà, R; Vega Palomares, R | 1 |
Samuel, D | 1 |
Alberti, A; Benvegnù, L; Boccato, S; Vario, A | 1 |
Nicolas, I; Pons, JA | 1 |
Bojarskas, J; Miseviciene, V | 1 |
Bailly, F; Chevallier, M; Chevallier, P; Rocca, P; Trépo, C; Zoulim, F | 1 |
Abou Ayache, R; Bridoux, F; Goujon, JM; Provôt, F; Touchard, G | 1 |
Yano, K; Yano, M; Yatsuhashi, H | 1 |
Abraczinskas, DR; Bhan, AK; Chung, RT; Cosimi, AB; Leung, JY; Pascual, M; Terella, AM | 1 |
Backmund, M; Diepolder, HM; Gerlach, JT; Gruener, NH; Jung, MC; Pape, GR; Schirren, CA; Schraut, WW; Ulsenheimer, A; Waechtler, M; Zachoval, R | 1 |
Martinón-Torres, F | 1 |
Al-Jaser, NM; Serebour, FE; Shobokshi, OA; Skakni, LI | 1 |
Betancourt-González, A; de la Serna-Higuera, C; Martín-Arribas, MI; Martínez-Moreno, J; Pérez-Villoria, A; Rodríguez-Gómez, SJ | 1 |
Chan, JW; Chan, YH; Cheng, CW; Fu, CL; Lee, MP; Li, SS; Yiu, SF | 1 |
Hrnicek, MJ; Mailliard, ME | 1 |
Buti, M | 1 |
Alter, H; Heller, T; Herrine, S; Hoofnagle, J; Liang, TJ; Mizukoshi, E; Nascimbeni, M; Rahman, F; Rehermann, B; Sobao, Y | 1 |
Santantonio, T | 1 |
Anand, BS; Batash, S; Bini, EJ; Chaudhari, S; Dieterich, DT; Park, J; Pimstone, NR | 1 |
Pearlman, BL | 1 |
Blum, HE; Moradpour, D | 1 |
Berenguer, J; Berenguer, M; Calvo, F; Carrasco, D; Palau, A; Prieto, M; Rayón, JM | 1 |
Gładysz, A; Inglot, M | 1 |
Beld, MG; den Hollander, JG; Ruys, TA; van der Ende, ME; van der Meer, JT | 1 |
Bernard, EJ | 1 |
Offner, F; Sagmeister, M; Sprenger, R | 1 |
Baumgarten, A; Bieniek, B; Bogner, JR; Hoffmann, C; Jessen, H; Kroidl, A; Rockstroh, JK; Schewe, CK; Spengler, U; Vogel, M | 1 |
Begović, V; Dokić, M | 1 |
Heathcote, J; Main, J | 1 |
Zeuzem, S | 1 |
Chen, DS; Chen, PJ; Hsieh, TH; Kao, JH; Lai, MY | 1 |
Baz, P; Daniel, F; Haddad, F; Koussa, S; Sayegh, R; Yaghi, C | 1 |
Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J | 1 |
Asboe, D; Atkins, M; Bower, M; Browne, RE; Gazzard, BG; Gilleece, YC; Mandalia, S; Nelson, MR | 1 |
Cheong-Lee, C; Ford, JA; Wong, VK; Yoshida, EM | 1 |
Allen, TM; Casson, DR; Chung, RT; Day, CL; Gandhi, RT; Kim, AY; Klenerman, P; Lauer, GM; Li, B; Lucas, M; Ouchi, K; Paranhos-Baccala, G; Reiser, M; Schulze Zur Wiesch, J; Sheridan, I; Timm, J; Walker, BD | 1 |
Cianciara, J; Horban, A; Jabłońska, J; Walewska-Zielecka, B | 1 |
Delić, D; Nesić, Z; Prostran, M; Simonović, J; Svirtlih, N | 1 |
Duvnjak, M; Lerotić, I; Pavić, T; Tomasić, V; Virović, L | 1 |
Chiodo, F; Cristoni, L; Manfredi, R; Marinacci, G; Pavoni, M; Sabbatani, S | 1 |
Batisse, D; Chaix, ML; Dupont, C; Fontaine, H; Piketty, C; Pol, S; Rouveix, E; Rouzioux, C; Serpaggi, J; Vallet-Pichard, A; Viard, JP; Weiss, L | 1 |
Atripaldi, L; Bellopede, P; Conca, P; Patarino, T; Perrella, A; Perrella, O; Ruggiero, L; Sbreglia, C; Sorrentino, P; Tarantino, G | 1 |
Benhamou, Y; Bonnard, P; Caumes, E; Dominguez, S; Ghosn, J; Katlama, C; Pialoux, G; Schruniger, A; Simon, A; Thibault, V; Valantin, MA | 1 |
Daruich, J; Fainboim, H; Frider, B | 1 |
Diepolder, HM; Gruener, NH; Klenerman, P; Loughry, A; Lucas, M; Pape, GR; Seth, NP; Tilman Gerlach, J; Ulsenheimer, A; Wucherpfennig, KW | 1 |
Buffet, C | 1 |
Fernández-Carbia, A; González-Lassalle, E; Marxuach-Cuétara, AM; Ríos-Bedoya, CF; Rodríguez-Orengo, JF; Rodríguez-Torres, M; Salgado-Mercado, R | 1 |
Bailey, KW; Blatt, LM; Gowen, BB; Jung, KH; Pace, AM; Sidwell, RW; Smee, DF; Wong, MH | 1 |
Lindhardt, BØ; Peters, L | 1 |
Etani, Y; Hasegawa, Y; Mushiake, S; Ozono, K; Tajiri, H | 1 |
Korochkina, OV; Sobchak, DM; Sobolevskaia, OL | 1 |
Cincin, A; Imeryuz, N; Ozdogan, O; Tahan, V; Tozun, N | 1 |
Encke, J; Stremmel, W; Weigand, K | 1 |
Bosco, G; de Gennaro, M; Fiorini, I; Luchi, S; Meini, M; Moneta, S; Ricciardi, L; Scasso, A | 1 |
Axel, B; Berg, T; Bienek, B; Bruno, R; Clotet, B; Danta, M; Grünhage, F; Haerter, G; Klausen, G; Lutz, T; Mayr, C; Nattermann, J; Nischalke, HD; Rausch, M; Rockstroh, JK; Sauerbruch, T; Schewe, K; Spengler, U; Tural, C; Vogel, M | 1 |
Benito, JM; Rallón, NI; Soriano, V | 1 |
Morelli, J; Senecal, DL | 1 |
Clemente Ricote, G; Díaz Sánchez, A; Matilla Peña, A; Merino Rodríguez, B; Núñez Martínez, O | 1 |
Maleev, VV; Pacechnikov, VD; Sannikova, IV | 1 |
Amrani, N; Benaïssa, A; Guedira, MM; Kabbaj, N; Mohammadi, M; Sentissi, S | 1 |
Beroy, GJ; Mendoza, SL; Mercoleza, VD; Santiago, LT; Uylangco, CV | 1 |
Main, J | 1 |
Fisher-Hoch, SP; Khan, JA; Khurshid, M; McCormick, JB; Mirza, S; Rehman, S | 1 |
DePablos, JM; Hernández, J; Jurado, M; Molina, MA; Navarro, JM | 1 |
Couriel, JM; Rakshi, K | 1 |
Markovic, N; Markovic, O; Markovic, S; Roberts, J | 1 |
Dhumeaux, D; Marcellin, P; Pawlotsky, JM; Trépo, C | 1 |
Lugo, RA; Nahata, MC | 1 |
Dusheiko, GM; Zuckerman, AJ | 1 |
Andreeff, M; Baxter, B; Couch, RB; Englund, JA; Goodrich, JM; Lewis, V; Luna, MA; Mirza, N; Raad, II; Whimbey, E | 1 |
Dusheiko, GM | 1 |
Belghiti, J; Benhamou, JP; Bernuau, J; Degott, C; Durand, F; Erlinger, S; Marcellin, P; Molas, G; Sauvanet, A; Sicot, C | 1 |
Najm, W | 1 |
Castillo-Ochando, F; Díaz-Torres, M; Pajarón de Ahumada, M; Sánchez-Flores, F; Sánchez-Solís de Querol, M; Sayed-Sancho, N | 1 |
Delwaide, J | 1 |
de Pablos Gallego, JM; Escobar Vedia, JL; Ferrer Chaves, C; Hernández Mohedo, F; Jurado Chacón, M; Navarro Marí, JM | 1 |
Gros-Desormeaux, A; Jouannault, S; Odièvre, M; Tison, M | 1 |
Hoepelman, AI | 1 |
McHutchison, JG; Pianko, S | 1 |
Barben, JU; Robertson, CF; Robinson, PJ | 1 |
Ray, SC; Sulkowski, MS; Thomas, DL | 1 |
Becquemont, L; Broly, F; Chazouilleres, O; Funck-Brentano, C; Jaillon, P; Poirier, JM; Poupon, R; Serfaty, L | 1 |
Dowling, JN; Guevarra, LO; Postic, B | 1 |
Ayrosa-Galvão, PA; Castro, IO | 1 |
Everard, ML; Milner, AD | 1 |
Ghamande, AR; Mogre, VM; Shah, U | 1 |
Chambers, C; Chernesky, MA; Dolovich, MB; Mahony, JB; Newhouse, MT | 1 |
Ajgaonkar, VS; Mogre, VM | 1 |
Clark, A; Everard, M; Milner, AD | 1 |
Dunne, N; White, PA | 1 |
Copeland, JG; Grogan, TM; Icenogle, TB; Minnich, LL; Ray, CG | 1 |
Milner, AD | 1 |
Cameron, D; Clay, M; Silverman, M | 1 |
Barry, W; Cockburn, F; Cornall, R; Price, JF; Sutherland, G; Vardag, A | 1 |
52 review(s) available for ribavirin and Acute Disease
Article | Year |
---|---|
Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.
Topics: Acute Disease; Blood Transfusion; Foodborne Diseases; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Ribavirin; Treatment Failure | 2017 |
Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.
Topics: Acute Disease; Age Factors; Animals; Antiviral Agents; Chronic Disease; Disease Transmission, Infectious; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Ribavirin; Sex Factors; Transplant Recipients | 2019 |
Pharmacological interventions for acute hepatitis C infection.
Topics: Acute Disease; Antiviral Agents; Hepatitis C; Humans; Interferon-alpha; Interferon-beta; Network Meta-Analysis; Randomized Controlled Trials as Topic; Ribavirin; Viral Hepatitis Vaccines | 2018 |
Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
Topics: Acute Disease; Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepatitis C; HIV Infections; HIV Seropositivity; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2015 |
Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Network Meta-Analysis; Polyethylene Glycols; Quality of Life; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Viral Hepatitis Vaccines | 2017 |
Therapy of acute hepatitis C: a review of literature.
Topics: Acute Disease; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2008 |
Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges?
Topics: Acute Disease; Antiviral Agents; CD4 Lymphocyte Count; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral | 2009 |
Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations.
Topics: Acute Disease; Adult; Antiviral Agents; Child; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Ribavirin; Sweden | 2009 |
Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?
Topics: Acute Disease; Antiviral Agents; Eukaryotic Initiation Factor-4E; Humans; IMP Dehydrogenase; Leukemia, Myeloid; Neoplasms; Protein Binding; Ribavirin | 2010 |
Acute hepatitis C treatment.
Topics: Acute Disease; Antiviral Agents; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Patient Selection; Ribavirin; Treatment Outcome | 2010 |
[Current status of acute hepatitis C].
Topics: Acute Disease; Antiviral Agents; Asymptomatic Diseases; Comorbidity; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Ribavirin; Risk Factors; RNA, Viral; Sexual Behavior; Spain; Substance Abuse, Intravenous; Viremia | 2011 |
Acute hepatitis C in an HIV-infected patient: a case report and review of literature.
Topics: Acute Disease; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; Homosexuality; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load | 2013 |
Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection.
Topics: Acute Disease; Antiviral Agents; Contraindications; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Remission, Spontaneous; Ribavirin | 2012 |
[Management of patients with hepatitis C virus infection. Virological tests].
Topics: Acute Disease; Adult; Algorithms; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Biomarkers; Capsid; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Interferons; Male; Monitoring, Physiologic; Polymerase Chain Reaction; Prognosis; Ribavirin; RNA, Viral; Time Factors; Viral Load | 2002 |
[What are the indications for treatment of acute hepatitis C?].
Topics: Acute Disease; Adult; Antiviral Agents; Clinical Enzyme Tests; Clinical Trials as Topic; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Interferon alpha-2; Interferon-alpha; Interferon-beta; Male; Meta-Analysis as Topic; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Substance-Related Disorders; Time Factors; Transaminases; Transfusion Reaction | 2002 |
[Treatment of hepatitis C after liver transplantation].
Topics: Acute Disease; Animals; Drug Therapy, Combination; Follow-Up Studies; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunoglobulins; Immunosuppression Therapy; Interferons; Liver Transplantation; Pan troglodytes; Postoperative Care; Postoperative Complications; Preoperative Care; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Virus Replication | 2002 |
[Treatment of chronic hepatitis C in special groups].
Topics: Acute Disease; Adult; Antiviral Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Follow-Up Studies; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Liver Transplantation; Mental Disorders; Renal Dialysis; Ribavirin; Thalassemia; Time Factors | 2002 |
[Treatment of acute hepatitis C].
Topics: Acute Disease; Adult; Antiviral Agents; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Female; Hepatitis C; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Interferon alpha-2; Interferon-alpha; Interferon-beta; Male; Meta-Analysis as Topic; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Time Factors | 2002 |
[Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
Topics: Acute Disease; Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Depression; Drug Evaluation; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Hyperbilirubinemia; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Spain; Thyroiditis; Viral Load; Viremia | 2002 |
Therapy of acute hepatitis C.
Topics: Acute Disease; Antiviral Agents; Hepatitis C; Humans; Interferons; Ribavirin | 2002 |
[Current treatment options for acute bronchiolitis in children].
Topics: Acute Disease; Adrenal Cortex Hormones; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Child, Preschool; Clinical Trials as Topic; Epinephrine; Female; Humans; Infant; Male; Oxygen Inhalation Therapy; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors | 2003 |
[Screening and treatment of acute hepatitis C].
Topics: Acute Disease; Antiviral Agents; Disease Progression; Drug Administration Schedule; Hepatitis C; Humans; Interferon-alpha; Mass Screening; Ribavirin; Risk Factors; Treatment Outcome | 2003 |
[Renal damage during type II cryoglobulinemia].
Topics: Acute Disease; Adrenal Cortex Hormones; Antiviral Agents; Biopsy; Cryoglobulinemia; Female; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney; Kidney Diseases; Male; Microscopy, Electron; Middle Aged; Nephritis; Nephrotic Syndrome; Plasma Exchange; Prognosis; Ribavirin | 2003 |
[Hepatitis C].
Topics: Acute Disease; Chronic Disease; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferons; Japan; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral | 2003 |
Current treatment for acute viral bronchiolitis in infants.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Bronchiolitis, Viral; Fluid Therapy; Humans; Immunotherapy; Infant; Infant, Newborn; Mucus; Ribavirin; Steroids | 2003 |
The role of the laboratory in the diagnosis and management of chronic hepatitis C patients.
Topics: Acute Disease; Biopsy, Needle; Clinical Laboratory Techniques; Enzyme-Linked Immunosorbent Assay; Female; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Immunohistochemistry; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Saudi Arabia; Sensitivity and Specificity | 2003 |
[Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
Topics: Acute Disease; Antiviral Agents; Forecasting; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Kinetics; Remission, Spontaneous; Ribavirin; RNA, Viral; Viral Load; Viremia | 2004 |
Treatment of acute hepatitis C.
Topics: Acute Disease; Antiviral Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Interferon-beta; Interferons; Ribavirin | 2004 |
Hepatitis C treatment update.
Topics: Acute Disease; Adjuvants, Immunologic; Algorithms; Antiviral Agents; Chronic Disease; Decision Trees; Disease Progression; Drug Monitoring; Drug Therapy, Combination; Forecasting; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Patient Compliance; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; RNA, Viral; Severity of Illness Index; Treatment Outcome; United States; Viral Load | 2004 |
[Hepatitis C].
Topics: Acute Disease; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Time Factors | 2004 |
[Treatment strategies of acute and chronic hepatitis C].
Topics: Acute Disease; Antiviral Agents; Drug Administration Schedule; Drug Carriers; Drug Therapy, Combination; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin | 2002 |
Treatment of hepatitis C.
Topics: Acute Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Maximum Tolerated Dose; Polyethylene Glycols; Prognosis; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Assessment; Severity of Illness Index; Treatment Outcome; Viral Load | 2005 |
[Treatment of hepatitis C virus infection].
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Longitudinal Studies; Meta-Analysis as Topic; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Viral Load | 2005 |
[Current treatment of hepatitis C virus infection].
Topics: Acute Disease; Amantadine; Animals; Antiviral Agents; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Recurrence; Ribavirin; Transaminases; Treatment Failure; Viral Envelope Proteins; Viral Hepatitis Vaccines | 2005 |
[Hepatitis C--treatment of untreated (naive) patients].
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
Topics: Acute Disease; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2006 |
[Acute hepatitis. Biological hepatic anomalies in asymptomatic persons].
Topics: Acute Disease; Adult; Antiviral Agents; Cholestasis; Chronic Disease; Clinical Enzyme Tests; Diagnosis, Differential; France; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Hepatitis D; Hepatitis D, Chronic; Hepatitis, Viral, Human; Humans; Infectious Disease Transmission, Vertical; Interferon-alpha; Phosphoric Monoester Hydrolases; Prevalence; Ribavirin; Transaminases | 2006 |
[Acute hepatitis C virus infection--clinical manifestations, diagnosis and treatment].
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |
Treatment of hepatitis C virus infection.
Topics: Acute Disease; Amantadine; Antiviral Agents; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
[Adaptive cell immune response against the hepatitis C virus infection].
Topics: Acute Disease; Animals; Antiviral Agents; CD8-Positive T-Lymphocytes; Cells, Cultured; Disease Models, Animal; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Immunity, Cellular; Interferon-alpha; Killer Cells, Natural; Mutation; Pan troglodytes; Ribavirin; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; Time Factors; Virus Replication | 2007 |
Hepatitis C virus infection: a current review.
Topics: Acute Disease; Antiviral Agents; Chronic Disease; Genotype; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors | 2007 |
Hepatitis C: clinical aspects.
Topics: Acute Disease; Chronic Disease; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Ribavirin | 1995 |
Management of acute bronchiolitis.
Topics: Acute Disease; Bronchiolitis, Viral; Bronchodilator Agents; Cross Infection; Diagnosis, Differential; Humans; Infant; Infant, Newborn; Monitoring, Physiologic; Respiration, Artificial; Ribavirin; Risk Factors | 1994 |
[Treatment of viral hepatitis C].
Topics: Acute Disease; Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferon Type I; Interferon-beta; Recombinant Proteins; Ribavirin | 1994 |
Pathogenesis and treatment of bronchiolitis.
Topics: Acute Disease; Adolescent; Adrenergic beta-Agonists; Aerosols; Age Factors; Bronchiolitis, Viral; Child; Child, Preschool; Clinical Trials as Topic; Humans; Infant; Respiratory Syncytial Viruses; Ribavirin; Time Factors | 1993 |
Treatment of chronic viral hepatitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Chronic Disease; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Interferon-alpha; Ribavirin | 1993 |
Summary: antiviral treatment of hepatitis C virus.
Topics: Acute Disease; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Liver Transplantation; Ribavirin | 1996 |
Viral hepatitis: how to manage type C and D infections.
Topics: Acute Disease; Aged; Antiviral Agents; Chronic Disease; Disease Progression; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin | 1997 |
[Update on hepatitis C: potential transmission by invasive medical examinations; new therapeutic modalities (1)].
Topics: Acute Disease; Antiviral Agents; Chronic Disease; Combined Modality Therapy; Cross Infection; Disease Progression; Hepatitis C; Humans; Interferons; Ribavirin | 1998 |
Treatment of hepatitis C with interferon and ribavirin.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Recurrence; Ribavirin | 2000 |
The respiratory syncitial virus and its role in acute bronchiolitis.
Topics: Acute Disease; Animals; Antibodies, Viral; Blood Platelets; Bronchiolitis, Viral; Humans; Immunoglobulin E; Immunoglobulin G; Monocytes; Neutrophils; Platelet Membrane Glycoproteins; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; T-Lymphocytes, Cytotoxic; Thrombospondins; Viral Vaccines | 1992 |
Ribavirin and acute bronchiolitis in infancy.
Topics: Acute Disease; Bronchiolitis; Child; Child, Preschool; Humans; Infant; Ribavirin; Ribonucleosides | 1988 |
16 trial(s) available for ribavirin and Acute Disease
Article | Year |
---|---|
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
Topics: Acute Disease; Administration, Oral; Adult; Antiviral Agents; Benzimidazoles; Cohort Studies; Drug Administration Schedule; Fluorenes; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferons; Male; Middle Aged; Ribavirin; Sexual and Gender Minorities; Sofosbuvir; Sustained Virologic Response; Uridine Monophosphate; Viral Load | 2019 |
Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Coinfection; Drug Administration Schedule; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Young Adult | 2013 |
Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin.
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Young Adult | 2014 |
Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection.
Topics: Acute Disease; Adult; Antiviral Agents; Cohort Studies; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viremia; Young Adult | 2009 |
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Remission, Spontaneous; Ribavirin; Treatment Outcome | 2003 |
Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin.
Topics: Acute Disease; Adult; Antiviral Agents; Disease Transmission, Infectious; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Seropositivity; Homosexuality, Male; Humans; Interferon alpha-2; Interferon-alpha; London; Male; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Treatment Outcome; Viral Load | 2005 |
Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
Topics: Acute Disease; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2006 |
Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2007 |
Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Cell Line, Tumor; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-6; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; STAT3 Transcription Factor; Treatment Outcome | 2007 |
A double-blind, placebo-controlled evaluation of ribavirin in the treatment of acute measles.
Topics: Acute Disease; Age Factors; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infant; Male; Measles; Placebos; Ribavirin; Ribonucleosides; Sex Factors | 1981 |
Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C.
Topics: Acute Disease; Acyltransferases; Adult; Aged; Antimetabolites; Antiviral Agents; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Treatment Outcome | 2002 |
The effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide on acute viral hepatitis.
Topics: Acute Disease; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Hepatitis, Viral, Human; Humans; Male; Ribavirin; Ribonucleosides; Time Factors | 1977 |
Treatment of acute viral hepatitis with ribavirin.
Topics: Acute Disease; Adolescent; Adult; Double-Blind Method; Female; Hepatitis, Viral, Human; Humans; Liver Function Tests; Male; Ribavirin | 1992 |
Ribavirin in acute viral hepatitis.
Topics: Acute Disease; Adolescent; Adult; Double-Blind Method; Hepatitis, Viral, Human; Humans; Middle Aged; Ribavirin | 1991 |
Ribavirin and acute bronchiolitis in infancy.
Topics: Acute Disease; Bronchiolitis; Humans; Infant; Nebulizers and Vaporizers; Ribavirin; Ribonucleosides | 1989 |
Ribavirin aerosol for acute bronchiolitis.
Topics: Acute Disease; Aerosols; Bronchiolitis, Viral; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Male; Random Allocation; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Ribonucleosides | 1986 |
92 other study(ies) available for ribavirin and Acute Disease
Article | Year |
---|---|
[Acute hepatitis C].
Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome | 2002 |
A Less Common Cause of Acute Hepatitis in Kidney Transplant Recipients: A Case Series.
Topics: Acute Disease; Hepatitis E; Hepatitis E virus; Humans; Kidney Transplantation; Ribavirin; Transplant Recipients | 2022 |
Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience.
Topics: Acute Disease; Antiviral Agents; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin M; Kidney; Pancreatitis; Retrospective Studies; Ribavirin; RNA, Viral; Transplant Recipients | 2022 |
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
Topics: 2-Naphthylamine; Acute Disease; Adult; Aged; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; Fluorenes; Germany; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Hypertension; Imidazoles; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Male; Middle Aged; Pleural Effusion; Proline; Pyrrolidines; Registries; Renal Insufficiency, Chronic; Ribavirin; Ritonavir; RNA, Viral; Severity of Illness Index; Simeprevir; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Uridine Monophosphate; Valine | 2019 |
The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.
Topics: Acute Disease; Aged; Biomarkers; Blood Platelets; Ceftazidime; COVID-19; COVID-19 Drug Treatment; Dyspnea; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Hypoxia; Lung; Male; Methylprednisolone; Middle Aged; Pulmonary Embolism; Respiratory Distress Syndrome; Ribavirin; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Treatment with ribavirin of acute hepatitis and severe renal damage in an immunocompetent patient.
Topics: Acute Disease; Aged; Antiviral Agents; Hepatitis E; Humans; Kidney Diseases; Male; Ribavirin; Severity of Illness Index | 2019 |
Successful treatment with sofosbuvir and daclatasvir plus ribavirin in acute hepatitis C-infected patient with hepatic decompensation.
Topics: Acute Disease; Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Hepatitis C; Humans; Imidazoles; Liver Failure; Male; Pyrrolidines; Ribavirin; RNA, Viral; Sofosbuvir; Sustained Virologic Response; Valine | 2019 |
Spontaneous clearance and treatment of acute hepatitis C infection in HIV-positive men with 48 weeks of interferon-alpha and ribavirin.
Topics: Acute Disease; Adult; Antiviral Agents; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2013 |
Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection.
Topics: Acute Disease; Adult; Antiviral Agents; Biomarkers; Chemokine CXCL10; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2013 |
Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.
Topics: Acute Disease; Adult; Age Distribution; Antiviral Agents; Case-Control Studies; Confidence Intervals; Disease Progression; Egypt; Female; GB virus C; Genotype; Hepacivirus; Hepatitis C; Humans; Incidence; Interferons; Interleukins; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Prospective Studies; Ribavirin; RNA, Viral; Sex Distribution; Statistics, Nonparametric; Treatment Outcome; Viral Load; Viremia | 2014 |
Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus.
Topics: Acetylcysteine; Acute Disease; Adult; Antibodies, Viral; Antiviral Agents; Asia, Southeastern; Cesarean Section; Combined Modality Therapy; Emergencies; Female; Hepatitis E; Hepatitis E virus; Humans; Immunity, Maternally-Acquired; Immunoglobulin G; Immunoglobulin M; Infant, Newborn; Liver Failure; Liver Transplantation; Plasma; Pregnancy; Pregnancy Complications, Infectious; Ribavirin | 2014 |
Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion.
Topics: Acute Disease; Aged; Animals; Antiviral Agents; Biomarkers; Food Microbiology; Genotype; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Male; Meat; Phylogeny; Ribavirin; Risk Factors; RNA, Viral; Swine; Treatment Outcome; Zoonoses | 2015 |
Acute rejection of non-functional renal grafts in dialysis patients after starting treatment with interferon and ribavirin.
Topics: Acute Disease; Antiviral Agents; Female; Graft Rejection; Humans; Interferons; Kidney Transplantation; Male; Middle Aged; Renal Dialysis; Ribavirin | 2014 |
Acute hepatitis C in HIV-1 infected Japanese Cohort: single center retrospective cohort study.
Topics: Acute Disease; Adult; Asian People; Female; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Treatment Outcome | 2014 |
[Acute outbreak of hepatitis C in human immunodeficiency virus-infected patients].
Topics: Acute Disease; Adult; Anti-HIV Agents; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Immunocompromised Host; Incidence; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Sexually Transmitted Diseases; Spain | 2015 |
[A case of chronic hepatitis C with pancreas divisum and acute pancreatitis during combination treatment with telaprevir/peginterferon/ribavirin].
Topics: Acute Disease; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2014 |
Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study.
Topics: Acute Disease; Allografts; Antiviral Agents; Biopsy; Drug Therapy, Combination; Female; Graft Rejection; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Middle Aged; Nephrectomy; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Renal Insufficiency, Chronic; Reoperation; Ribavirin; Risk Factors; Therapeutics; Time Factors | 2014 |
Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Topics: Acute Disease; Aged; Aged, 80 and over; Antiviral Agents; Drug Administration Schedule; Female; France; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Recurrence; Remission Induction; Ribavirin; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Outcome; Viral Load | 2016 |
Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?
Topics: Acute Disease; Adult; Aged; Antibodies, Viral; Antiviral Agents; Female; Glucocorticoids; Hepatitis E; Hepatitis E virus; Hepatitis, Alcoholic; Hospitalization; Humans; Immunoglobulin G; Immunoglobulin M; Male; Mass Screening; Middle Aged; Prognosis; Retrospective Studies; Ribavirin; Survival Analysis; Treatment Outcome | 2015 |
Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients.
Topics: Acute Disease; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Proline; Prospective Studies; Quality of Life; Recombinant Proteins; Ribavirin | 2016 |
Management of acute HVE infection in a patient treated with rituximab for rheumatoid arthritis.
Topics: Acute Disease; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Female; Hepatitis E; Humans; Immunocompromised Host; Middle Aged; Ribavirin; Rituximab | 2016 |
Liver transplantation for fulminant genotype 2a/c hepatitis C virus marked by a rapid recurrence followed by cure.
Topics: Acute Disease; Administration, Oral; Antiviral Agents; Carbamates; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Risk Factors; Sofosbuvir; Valine | 2017 |
Peginterferon monotherapy for the treatment of acute hepatitis C in HIV-coinfected patients.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin | 2008 |
Xerostomia and lichenoid reaction in a hepatitis C patient treated with interferon-alpha: a case report.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Lichen Planus, Oral; Male; Middle Aged; Ribavirin; Xerostomia | 2008 |
Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis.
Topics: Acute Disease; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Pancreatitis; Polyethylene Glycols; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load | 2009 |
Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.
Topics: Acute Disease; Adult; Antiviral Agents; Clinical Trials as Topic; Computer Simulation; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Germany; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon alpha-2; Interferon-alpha; Linear Models; Male; Middle Aged; Models, Economic; Polyethylene Glycols; Practice Guidelines as Topic; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Young Adult | 2010 |
Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort.
Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Belgium; Drug Therapy, Combination; Female; France; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon Type I; Luxembourg; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Registries; Remission, Spontaneous; Ribavirin; Risk Factors; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Young Adult | 2010 |
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.
Topics: Acute Disease; Adult; Antiviral Agents; Australia; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; RNA, Viral; Seroepidemiologic Studies; Substance-Related Disorders; Treatment Outcome | 2010 |
[Treatment of acute hepatitis C].
Topics: Acute Disease; Antiviral Agents; Clinical Trials as Topic; Hepatitis C; Humans; Interferons; Meta-Analysis as Topic; Ribavirin; Viral Load | 2005 |
[Consensus conference on acute bronchiolitis (IV): Treatment of acute bronchiolitis. Review of scientific evidence].
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Bronchiolitis; Bronchodilator Agents; Cholinergic Antagonists; Epinephrine; Evidence-Based Medicine; Helium; Humans; Oxygen; Physical Therapy Modalities; Respiration, Artificial; Ribavirin; Saline Solution, Hypertonic; Surface-Active Agents | 2010 |
Peginterferon alpha-2b and acute allograft failure in a heart transplant recipient.
Topics: Acute Disease; Antiviral Agents; Autopsy; Disease Progression; Fatal Outcome; Graft Rejection; Heart Transplantation; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Time Factors; Transplantation, Homologous | 2010 |
The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Disease Progression; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2011 |
Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report.
Topics: Acute Disease; Adult; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Ibuprofen; Interferon alpha-2; Interferon-alpha; Pericarditis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Withholding Treatment | 2011 |
Response-guided therapy for acute hepatitis C: applying concepts from chronic treatment.
Topics: Acute Disease; Antiviral Agents; Biomarkers; Drug Administration Schedule; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2011 |
Treatment of severe acute hepatitis E by ribavirin.
Topics: Acute Disease; Antiviral Agents; Hepatitis Antibodies; Hepatitis E; Humans; Liver; Liver Function Tests; Male; Middle Aged; Ribavirin; RNA, Viral | 2011 |
Low rate of sustained virological response in an outbreak of acute hepatitis C in HIV-infected patients.
Topics: Acute Disease; Adult; Antiviral Agents; Disease Outbreaks; Female; Follow-Up Studies; Genotype; Hepatitis C; Hepatitis C Antibodies; HIV Seropositivity; Homosexuality, Male; Humans; Interferon-alpha; Male; Middle Aged; Phylogeny; Retrospective Studies; Ribavirin; Risk Factors; Spain | 2012 |
Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Biopsy; Blotting, Western; CD8-Positive T-Lymphocytes; Cells, Cultured; Drug Resistance, Viral; Drug Therapy, Combination; Endopeptidases; Female; Gene Expression Profiling; Gene Expression Regulation; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Host-Pathogen Interactions; Humans; Immunohistochemistry; Interferon-alpha; Interferon-gamma; Liver; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Phosphorylation; Polyethylene Glycols; Recombinant Proteins; Ribavirin; STAT1 Transcription Factor; Switzerland; Time Factors; Transcription, Genetic; Treatment Outcome; Ubiquitin Thiolesterase | 2012 |
Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha.
Topics: Acute Disease; Adult; Aged; Biopsy; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Transplantation; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; Renal Insufficiency; Retrospective Studies; Ribavirin; Steroids; Transaminases; Treatment Outcome | 2012 |
The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C.
Topics: Acute Disease; Adult; Alanine Transaminase; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin | 2012 |
Acute hepatitis C virus infection in a nurse trainee following a needlestick injury.
Topics: Acute Disease; Aged; Antiviral Agents; Blood Specimen Collection; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Needlestick Injuries; Occupational Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Students, Nursing; Time Factors; Treatment Outcome; Young Adult | 2013 |
I favor therapy for hepatitis C virus recurrence after transplantation.
Topics: Acute Disease; Antiviral Agents; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Transplantation; Postoperative Complications; Recurrence; Ribavirin; RNA, Viral | 2002 |
[Treatment of acute hepatitis C with PEG-interferon and ribavirin].
Topics: Acute Disease; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Polyethylene Glycols; Ribavirin | 2003 |
[Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients].
Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Asthenia; Diarrhea; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Jaundice; Male; Middle Aged; Needlestick Injuries; Pain; Punctures; Recombinant Proteins; Retrospective Studies; Ribavirin; Serotyping; Sexual Behavior; Substance Abuse, Intravenous; Tattooing; Time Factors; Treatment Outcome | 2003 |
Recurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Aspartate Aminotransferases; Female; Glucocorticoids; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Prednisolone; Recombinant Proteins; Recurrence; Ribavirin | 2003 |
Peginterferon and ribavirin in a patient with acute hepatitis C.
Topics: Acute Disease; Adult; Biopsy, Needle; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Recombinant Proteins; Ribavirin; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Combined Modality Therapy; Convalescence; Diastole; Echocardiography; Echocardiography, Doppler, Pulsed; Female; Humans; Male; Methylprednisolone; Middle Aged; Prospective Studies; Respiration, Artificial; Ribavirin; Severe Acute Respiratory Syndrome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2003 |
Acute west nile virus in two patients receiving interferon and ribavirin for chronic hepatitis C.
Topics: Acute Disease; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Risk Assessment; West Nile Fever; West Nile virus | 2004 |
Effects of antiviral therapy on the cellular immune response in acute hepatitis C.
Topics: Acute Disease; Adult; Antiviral Agents; CD4-CD8 Ratio; Epitopes; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; T-Lymphocytes | 2004 |
Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pancreatitis; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome | 2004 |
Recurrent hepatitis C genotype 1b following liver transplantation: treatment with combination interferon-ribavirin therapy.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Ribavirin; Treatment Outcome | 2004 |
[Sexual transmission of hepatitis C in homosexual men].
Topics: Acute Disease; Adult; Antiviral Agents; Hepatitis C; HIV Infections; Homosexuality, Male; Humans; Lymphogranuloma Venereum; Male; Middle Aged; Netherlands; Prevalence; Proctitis; Ribavirin; Risk Factors; Sexual Behavior; Sexually Transmitted Diseases, Viral | 2004 |
PegIFN/ribavirin during acute HCV coinfection.
Topics: Acute Disease; Adult; Antiviral Agents; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load | 2004 |
Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
Topics: Acute Disease; Antiviral Agents; Colitis, Ulcerative; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Assessment; Sampling Studies; Severity of Illness Index; Treatment Outcome; Viral Load | 2005 |
[Therapy of acute hepatitis C infection].
Topics: Acute Disease; Antiviral Agents; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin | 2005 |
Successful treatment with peginterferon and ribavirin in a patient with acute hepatitis C evolving into chronicity.
Topics: Acute Disease; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
[Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C].
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Optic Neuropathy, Ischemic; Recombinant Proteins; Ribavirin | 2005 |
Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Female; Hearing Loss, Sensorineural; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.
Topics: Acute Disease; Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Epitopes, T-Lymphocyte; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lymphocyte Activation; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Up-Regulation; Viral Proteins | 2005 |
[Epidemic outbreak of acute hepatitis C--clinical course, histology and effectiveness of therapy].
Topics: Acute Disease; Aged; Antiviral Agents; Arteriosclerosis; Coronary Disease; Cross Infection; Disease Outbreaks; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Poland; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome | 2005 |
Treatment of anicteric acute hepatitis C with peginterferon alpha-2a plus ribavirin.
Topics: Acute Disease; Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis.
Topics: Acute Disease; Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Radiography; Ribavirin; Severity of Illness Index; Tomography Scanners, X-Ray Computed; Tuberculosis, Pulmonary | 2006 |
Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
Topics: Acute Disease; Adult; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; HIV-1; Homosexuality, Male; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Phylogeny; Recombinant Proteins; Retrospective Studies; Ribavirin; Sexual Behavior; Sexually Transmitted Diseases, Viral; Treatment Outcome | 2006 |
Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms.
Topics: Acute Disease; Adult; Antiviral Agents; Case-Control Studies; CD11 Antigens; Cell Count; Dendritic Cells; Disease Progression; Drug Combinations; Female; Flow Cytometry; Hepatitis A; Hepatitis C; Humans; Interferons; Lipopolysaccharide Receptors; Male; Middle Aged; Myeloid Cells; Ribavirin | 2006 |
[Primer treatment of acute and chronic hepatitis C].
Topics: Acute Disease; Antiretroviral Therapy, Highly Active; Antiviral Agents; Clinical Trials as Topic; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2006 |
Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses.
Topics: Acute Disease; Antigens, Viral; Antiviral Agents; Hepatitis C; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Interferon-alpha; Lymphocyte Activation; Ribavirin; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer | 2006 |
Combinatorial ribavirin and interferon alfacon-1 therapy of acute arenaviral disease in hamsters.
Topics: Acute Disease; Administration, Oral; Animals; Antiviral Agents; Arenaviridae Infections; Cricetinae; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Interferon Type I; Interferon-alpha; Placebos; Recombinant Proteins; Ribavirin; Survival Analysis; Time Factors | 2006 |
Acute exacerbation of hepatitis in a boy with chronic HCV genotype-2 infection after a 9-year period of normal transaminases levels.
Topics: Acute Disease; Antiviral Agents; Child; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Recombinant Proteins; Ribavirin; Transaminases | 2007 |
[Assessment of the values of immune response mediators in patients with acute hepatitis C receiving combined antiviral therapy].
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Biomarkers; Cytokines; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Immunoenzyme Techniques; Interferon-alpha; Male; Middle Aged; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Treatment Outcome; Virus Replication | 2006 |
Acute pancreatitis associated with the use of peginterferon.
Topics: Acute Disease; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |
[Acute hepatitis C infection: epidemiological and clinical aspects, and efficacy of interferon therapy].
Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Colonoscopy; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Ribavirin; Sexual Behavior; Substance Abuse, Intravenous | 2007 |
[Acute portal thrombosis in patients with hepatitis C treated with pegylated interferon and ribavirin].
Topics: Acute Disease; Adult; Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Portal Vein; Recombinant Proteins; Ribavirin; Thrombosis | 2008 |
[Respiratory lesions in Congo-Crimean hemorrhagic fever].
Topics: Acute Disease; Adult; Antiviral Agents; Blood Transfusion; Cytokines; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; Humans; Immunoglobulin G; Lung Diseases; Male; Respiratory Tract Infections; Ribavirin | 2007 |
[Acute pancreatitis during treatment for chronic viral hepatitis C].
Topics: Acute Disease; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Crimean Congo-haemorrhagic fever treated with oral ribavirin.
Topics: Acute Disease; Administration, Oral; Disease Outbreaks; General Surgery; Health Personnel; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; Humans; Immunoglobulin G; Immunoglobulin M; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Pakistan; Partial Thromboplastin Time; Platelet Count; Ribavirin | 1995 |
Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin.
Topics: Acute Disease; Adenoviridae Infections; Adult; Bone Marrow Transplantation; Cystitis; Hemorrhage; Humans; Male; Ribavirin | 1995 |
A new assay for intracellular measurement of inosine monophosphate dehydrogenase activity: a guide for better selection of patients for enzyme-targeted chemotherapy.
Topics: Acute Disease; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Therapy, Computer-Assisted; Humans; Image Processing, Computer-Assisted; IMP Dehydrogenase; Leukemia, Experimental; Leukemia, Myeloid; Reference Values; Ribavirin; Tumor Cells, Cultured | 1994 |
Update: outbreak of hantavirus infection--southwestern United States, 1993.
Topics: Acute Disease; Animals; Antibodies, Viral; Bunyaviridae Infections; Disease Outbreaks; Drugs, Investigational; Humans; Orthohantavirus; Peromyscus; Pulmonary Fibrosis; Respiratory Distress Syndrome; Ribavirin; Seroepidemiologic Studies; Southwestern United States | 1993 |
From the Centers for Disease Control and Prevention. Infectious diseases update: outbreak, hantavirus infection--southwestern United States, 1993.
Topics: Acute Disease; Animals; Antibodies, Viral; Bunyaviridae Infections; Disease Outbreaks; Drugs, Investigational; Humans; Orthohantavirus; Peromyscus; Pulmonary Fibrosis; Respiratory Distress Syndrome; Ribavirin; Seroepidemiologic Studies; Southwestern United States | 1993 |
Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia.
Topics: Acute Disease; Adult; Antigens, Viral; Antineoplastic Agents; Antiviral Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Hospitalization; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Leukemia; Nasopharynx; Pharynx; Pneumonia, Viral; Prospective Studies; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin | 1995 |
Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin.
Topics: Acute Disease; Adult; Antiviral Agents; Biopsy; Follow-Up Studies; Giant Cells; Hepatitis; Humans; Liver Failure; Liver Transplantation; Male; Recurrence; Ribavirin | 1997 |
[Ribavirin in the treatment of bronchiolitis caused by syncytial respiratory virus].
Topics: Acute Disease; Antiviral Agents; Bronchiolitis; Female; Humans; Infant; Infant, Newborn; Male; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Retrospective Studies; Ribavirin | 1997 |
Adenovirus pneumonitis successfully treated with intravenous ribavirin.
Topics: Acute Disease; Adenoviridae Infections; Adult; Antiviral Agents; Bone Marrow Transplantation; Humans; Injections, Intravenous; Leukemia, Myeloid; Male; Pneumonia, Viral; Ribavirin; Transplantation, Homologous | 1998 |
-Headache: an unrecognized risk of ribavirin in infants?
Topics: Acute Disease; Antiviral Agents; Bronchiolitis; Headache; Humans; Infant; Ribavirin | 1998 |
Needle-stick exposure in the health care setting: do not forget hepatitis C!
Topics: Acute Disease; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Health Personnel; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Needlestick Injuries; Netherlands; Primary Prevention; Ribavirin; Time Factors | 2000 |
Implementation of evidence-based management of acute bronchiolitis.
Topics: Acute Disease; Anti-Inflammatory Agents; Antiviral Agents; Australia; Bronchiolitis, Viral; Bronchodilator Agents; Child; Child, Preschool; Evidence-Based Medicine; Humans; Infant; Practice Guidelines as Topic; Ribavirin; Steroids; Theophylline | 2000 |
Needlestick transmission of hepatitis C.
Topics: Accidents, Occupational; Acute Disease; Adult; Anti-HIV Agents; Antiviral Agents; Asthenia; Exanthema; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Interferon alpha-2; Interferon-alpha; Internship and Residency; Lamivudine; Needlestick Injuries; Nelfinavir; Occupational Exposure; Physicians; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viremia; Zidovudine | 2002 |
Effect of ribavirin on murine cytomegalovirus infection.
Topics: Acute Disease; Animals; Cells, Cultured; Chronic Disease; Cytomegalovirus Infections; Cytopathogenic Effect, Viral; In Vitro Techniques; Mice; Ribavirin; Ribonucleosides; Viral Plaque Assay | 1976 |
Ciliary function, cell viability, and in vitro effect of ribavirin on nasal epithelial cells in acute rhinorrhea.
Topics: Acute Disease; Adolescent; Adult; Cell Survival; Cilia; Common Cold; Epithelial Cells; Epithelium; Humans; In Vitro Techniques; Middle Aged; Nasal Mucosa; Nasal Septum; Ribavirin | 1992 |
Ribavirin and acute bronchiolitis in infancy.
Topics: Acute Disease; Aerosols; Bronchiolitis; Humans; Infant; Ribavirin; Ribonucleosides | 1989 |
The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis.
Topics: Acute Disease; Adult; Child, Preschool; Female; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Infusions, Intravenous; Myocarditis; Myocardium; Ribavirin; Ribonucleosides | 1989 |
Ribavirin and acute bronchiolitis in infancy.
Topics: Acute Disease; Administration, Inhalation; Bronchiolitis; Humans; Infant; Nebulizers and Vaporizers; Particle Size; Ribavirin; Ribonucleosides | 1988 |